CI vs CLOV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jan 27, 2026

CI

62.5
AI Score
VS
CI Wins

CLOV

57.6
AI Score

Investment Advisor Scores

CI

63score
Recommendation
BUY

CLOV

58score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CI CLOV Winner
Forward P/E 9.1659 107.5269 CI
PEG Ratio 0.5623 0 Tie
Revenue Growth 9.5% 50.1% CLOV
Earnings Growth 165.4% 0.0% CI
Tradestie Score 62.5/100 57.6/100 CI
Profit Margin 2.3% -3.3% CI
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD CI

Frequently Asked Questions

Based on our detailed analysis, CI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.